Tag: report

The Viral Vectors and Plasmid DNA Manufacturing Market forecast indicates a surge past $6 billion by 2025, driven by gene therapy advancements. The report highlights market dynamics, growth prospects, and regulatory challenges impacting this sector. Discover innovative opportunities and key players in this evolving landscape.

The global photoacoustic imaging market is set to grow at a CAGR of 3.52%, driven by rising chronic diseases and tech advancements. Key players include Advantest and FUJIFILM. Notable growth is expected in the Asia Pacific due to high imaging equipment demand. Explore market trends, forecasts, and strategies.

Fiscal Year 2025 Earnings

In 2025 Q2, 3.5 million tons of cargo and 2.2 million passengers passed through the harbours of Tallinna Sadam. Compared to the same period previous year, the number of passengers increased by 3.8% i.e. 81 thousand passengers. Cargo volumes increased 8% i.e. 253 thousand tons. The number of vessel calls increased by 2.1%. The number of passengers travelling between the Estonian mainland and the main islands increased by 2.4%, the number of vehicles increased by 3.4%. The number of charter days of the icebreaker Botnica declined 63% comparing to last year.

WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing of its previously announced underwritten public offering of 22,222,223 shares of its common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering are expected to be approximately $200 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, Cogent has granted the underwriters a 30-day option to purchase up to an additional 3,333,333 shares of its common stock on the same terms and conditions. All of the securities in the offering are being sold by Cogent. The offering is expected to close on or about July 10, 2025, subject to the satisfaction of customary closing conditions.

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.